4.6 Article

Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource

Hirotaka Iwaki et al.

Summary: The study describes the genetic component of the Accelerating Medicines Partnership Parkinson's Disease platform, providing a solution for democratizing data access and analysis for the Parkinson's disease research community.

MOVEMENT DISORDERS (2021)

Review Clinical Neurology

Exploring the Genotype-Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers

Elisa Menozzi et al.

Summary: Variants in the GBA gene are the most common genetic risk factor for Parkinson's disease, with GBA-PD patients typically having more severe symptoms and faster disease progression. The impact of different GBA variants on clinical phenotype varies.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

The genetic architecture of Parkinson's disease

Cornelis Blauwendraat et al.

LANCET NEUROLOGY (2020)

Article Clinical Neurology

Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies

Lynne Krohn et al.

ANNALS OF NEUROLOGY (2020)

Article Clinical Neurology

Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease

Franziska Hopfner et al.

MOVEMENT DISORDERS (2020)

Review Neurosciences

Genetics of Parkinson's disease: An introspection of its journey towards precision medicine

Sara Bandres-Ciga et al.

NEUROBIOLOGY OF DISEASE (2020)

Article Genetics & Heredity

The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD

Letizia Straniero et al.

NEUROLOGY-GENETICS (2020)

Article Clinical Neurology

A rapid and low-cost test for screening the most common Parkinson's disease-related GBA variants

Letizia Straniero et al.

PARKINSONISM & RELATED DISORDERS (2020)

Article Endocrinology & Metabolism

Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?

Orly Goldstein et al.

MOLECULAR GENETICS AND METABOLISM (2019)

Article Clinical Neurology

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study

Naveed Malek et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Medicine, General & Internal

Lysosomal storage diseases

Frances M. Platt et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Clinical Neurology

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters

Roberto Cilia et al.

ANNALS OF NEUROLOGY (2016)

Review Biochemistry & Molecular Biology

The relationship between glucocerebrosidase mutations and Parkinson disease

Anna Migdalska-Richards et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Clinical Neurology

Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease

Yvette C. Wong et al.

MOVEMENT DISORDERS (2016)

Article Geriatrics & Gerontology

Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression

Albert A. Davis et al.

NEUROBIOLOGY OF AGING (2016)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Clinical Neurology

Differential effects of severe vs mild GBA mutations on Parkinson disease

Ziv Gan-Or et al.

NEUROLOGY (2015)

Article Genetics & Heredity

Significant Study of Population Stratification, Sensitivity Analysis and Trim and Fill Analyses on GBA Mutation and Parkinson's Disease

Jie Liu et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)

Article Clinical Neurology

Glucocerebrosidase mutations in primary parkinsonism

Rosanna Asselta et al.

PARKINSONISM & RELATED DISORDERS (2014)

Review Clinical Neurology

The Association Between β-Glucocerebrosidase Mutations and Parkinsonism

Matthew Swan et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)

Article Genetics & Heredity

Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling

Huma Q. Rana et al.

GENETICS IN MEDICINE (2013)

Article Clinical Neurology

Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome

Sophie E. Winder-Rhodes et al.

MOVEMENT DISORDERS (2012)

Article Medicine, General & Internal

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

E. Sidransky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY